80
Participants
Start Date
February 14, 2019
Primary Completion Date
July 17, 2021
Study Completion Date
July 17, 2021
adalimumab
Subcutaneous injection
Certolizumab
Subcutaneous injection
Etanercept
Subcutaneous injection
Golimumab
Subcutaneous injection
Secukinumab
Subcutaneous injection
Musgrave Park Hospital, Belfast
British Medical Association
OTHER
Psoriasis and Psoriatic Arthritis Alliance
UNKNOWN
Queen's University, Belfast
OTHER
Belfast Health and Social Care Trust
OTHER